Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001323800 | SCV001514730 | uncertain significance | Imerslund-Grasbeck syndrome | 2023-09-13 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 3369 of the CUBN protein (p.Ser3369Gly). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CUBN protein function. ClinVar contains an entry for this variant (Variation ID: 1023714). This variant has not been reported in the literature in individuals affected with CUBN-related conditions. This variant is present in population databases (rs145023719, gnomAD 0.2%). |
Gene |
RCV002251586 | SCV002522028 | uncertain significance | not provided | 2022-12-12 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002486295 | SCV002792158 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2022-01-04 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002251586 | SCV004225210 | uncertain significance | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing | BP4 |